SCHEMBL30911208

SCHEMBL30911208

CCCCOC(=O)N1CCN(c2c(C)cnn2C2COC2)[C@H](C)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GPR119 Q8TDV5 3/20 0.38
▸ ROCK2 O75116 4/20 0.35
▸ ROCK1 Q13464 4/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ MMP1 P03956 1/20 0.34
▸ MMP3 P08254 1/20 0.34
▸ MMP7 P09237 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ MMP13 P45452 1/20 0.34
▸ PIK3R1 P27986 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ SMYD3 Q9H7B4 2/20 0.33
▸ PLA2G2A P14555 2/20 0.33
▸ HRH2 P25021 1/20 0.33
▸ HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38653347 0.75 LMNA (0.38) LMNAPOLBSMN1; SMN2GPR119ALDH1A1
SCHEMBL30911167 0.73 GPR119 (0.46) LMNAGPR119PIK3R1PIK3CA
SCHEMBL30911135 0.73 GPR119 (0.46) LMNAGPR119PIK3R1PIK3CA
SCHEMBL38654099 0.72 GPR119 (0.46) LMNAGPR119PIK3R1PIK3CA
SCHEMBL30911096 0.72 SMARCA2 (0.48) LMNAGPR119PIK3R1PIK3CA
SCHEMBL18149413 0.71 GPR119 (0.41) LMNAPOLBSMN1; SMN2GPR119PIK3R1
SCHEMBL30019205 0.70 HRH3 (0.43) GPR119MMP1MMP3MMP7MMP9
SCHEMBL30911128 0.69 GPR119 (0.45) LMNAGPR119ALDH1A1MMP1MMP3
SCHEMBL2570900 0.68 POLB (0.51) LMNAPOLBSMN1; SMN2ALDH1A1MMP1
SCHEMBL11963107 0.67 GRM1 (0.39) LMNAPOLBSMN1; SMN2GPR119ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598915-A2 TETHERED HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2025-08-13 — — EP disclosed
WO-2024076670-A2 TETHERED HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-04-11 — — WO disclosed
Send feedback